These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38241815)

  • 1. ZNF131 facilitates the growth of hepatocellular carcinoma by acting as a transcriptional activator of SMC4 expression.
    Jin M; Mi Y; Li F; Ren F; Deng Y; Zheng P
    Biochem Biophys Res Commun; 2024 Feb; 696():149515. PubMed ID: 38241815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YAP1-activated ZNF131 promotes hepatocellular carcinoma cell proliferation through transcriptional regulation of PAIP1.
    Yin G; Jia S; Zhang Y; Xian Y; Guo Y; Liu Q
    Arch Biochem Biophys; 2024 Apr; 754():109921. PubMed ID: 38341068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel miR-219-SMC4-JAK2/Stat3 regulatory pathway in human hepatocellular carcinoma.
    Zhou B; Chen H; Wei D; Kuang Y; Zhao X; Li G; Xie J; Chen P
    J Exp Clin Cancer Res; 2014 Jun; 33(1):55. PubMed ID: 24980149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the structural maintenance of chromosome 4 protein is associated with tumor de-differentiation, advanced stage and vascular invasion of primary liver cancer.
    Zhou B; Yuan T; Liu M; Liu H; Xie J; Shen Y; Chen P
    Oncol Rep; 2012 Oct; 28(4):1263-8. PubMed ID: 22842912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIF-1-miR-219-SMC4 Regulatory Pathway Promoting Proliferation and Migration of HCC under Hypoxic Condition.
    Chen Y; Huang F; Deng L; Yuan X; Tao Q; Wang T; Li D; Fan Y; Peng Q; Tang D
    Biomed Res Int; 2019; 2019():8983704. PubMed ID: 31828143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression.
    Xu K; Xia P; Gongye X; Zhang X; Ma S; Chen Z; Zhang H; Liu J; Liu Y; Guo Y; Yao Y; Gao M; Chen Y; Zhang Z; Yuan Y
    Mol Metab; 2022 Sep; 63():101540. PubMed ID: 35798238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
    Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
    J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA-383-5p transcription.
    Hao F; Wang N; Zhang Y; Xu W; Chen Y; Fei X; Wang J
    Mol Carcinog; 2022 Nov; 61(11):975-988. PubMed ID: 35924788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-377-3p promotes cell proliferation and inhibits cell cycle arrest and cell apoptosis in hepatocellular carcinoma by affecting EGR1-mediated p53 activation.
    Li W; Li K; Wang Z; Fa Z
    Pathol Res Pract; 2022 Jun; 234():153855. PubMed ID: 35461040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-433-3p restrains the proliferation, migration and invasion of glioma cells via targeting SMC4.
    You A; Rao G; Wang J; Li J; Zhang Y; Gu J; Ge X; Zhang K; Gao X; Wu X; Cheng L; Zhu M; Wang D
    Brain Res; 2021 Sep; 1767():147563. PubMed ID: 34147470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
    Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
    Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coordination between ZNF217 and LSD1 contributes to hepatocellular carcinoma progress and is negatively regulated by miR-101.
    Si W; Zhao Y; Zhou J; Zhang Q; Zhang Y
    Exp Cell Res; 2019 Jun; 379(1):1-10. PubMed ID: 30898548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
    Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
    Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.
    Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L
    EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARHGAP9 suppresses the migration and invasion of hepatocellular carcinoma cells through up-regulating FOXJ2/E-cadherin.
    Zhang H; Tang QF; Sun MY; Zhang CY; Zhu JY; Shen YL; Zhao B; Shao ZY; Zhang LJ; Zhang H
    Cell Death Dis; 2018 Sep; 9(9):916. PubMed ID: 30206221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.
    Chen DB; Zhao YJ; Wang XY; Liao WJ; Chen P; Deng KJ; Cong X; Fei R; Wu X; Shao QX; Wei L; Xie XW; Chen HS
    Chin Med J (Engl); 2019 Jul; 132(13):1572-1581. PubMed ID: 31188160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
    Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
    Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of METTL5 inhibits the Myc pathway to downregulate PD-L1 expression and inhibits immune escape of hepatocellular carcinoma cells.
    Xu W; Liu S; Zhang G; Liu J; Cao G
    J Chemother; 2023 Sep; 35(5):455-464. PubMed ID: 36369791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1.
    Yang PW; Lu ZY; Pan Q; Chen TT; Feng XJ; Wang SM; Pan YC; Zhu MH; Zhang SH
    Phytomedicine; 2019 Apr; 57():18-29. PubMed ID: 30668319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.